Cannabinoid Receptor
The cannabinoid receptor (CB1 and CB2) is a member of G-protein coupled receptor which plays a significant role in physiologic processes such as cognitive and immune functions.
Products for Cannabinoid Receptor
- Cat.No. Product Name Information
-
GC10907
(±)-SLV 319
(±)-SLV319; (±)-BMS-646256
(±)-SLV 319 ((±)-SLV319) is the racemate of SLV319.
-
GC10028
(R)-SLV 319
CB1 receptor antagonist
-
GC63410
(Rac)-MRI-1867
(Rac)-MRI-1867
(Rac)-MRI-1867 ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R.
-
GC10753
(S)-SLV 319
Ibipinabant|BMS 646256|JD 5001
(S)-SLV 319 (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM.
-
GC16403
2-Arachidonoyl Glycerol
2-AG
An endogenous agonist of the cannabinoid (CB) receptors CB1 and CB2
-
GC16196
2-Palmitoylglycerol
Glycerol-β-palmitate, 2-Hexadecanoyl Glycerol, 2-Monopalmitin, 2-PG
Endogenous fatty acid glycerol ester
-
GC17100
4-Quinolone-3-Carboxamide CB2 Ligand
4Q3C CB2 Ligand
ligand of the CB2 receptor
-
GC15850
4-Quinolone-3-Carboxamide Furan CB2 Agonist
4Q3C CB2 Agonist
4-Quinolone-3-Carboxamide Furan CB2 Agonist is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM.
-
GC18199
A-836339
A-836339 is a synthetic cannabinoid (CB) which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 receptor (Ki = 270 nM).
-
GC16480
AM 281
AM 281 is a high-affinity and selective CB2 receptor antagonist with an IC50 of 13μM. AM 281 is used to study the role of the endocannabinoid system in various physiological and pathological processes and has potential applications in the research of inflammation, pain, and neurodegenerative diseases.
-
GC62835
AM-6538
AM6538 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist.
-
GC15414
AM1241
AM1241 is an aminoalkylindole analog and a selective ligand for the type II cannabinoid receptor (CB2), exhibiting higher affinity for the CB2 receptor (Ki=3.4nM) than for the CB1 receptor (Ki=280nM).
-
GC15717
AM251
AM251 is a cannabinoid receptor type 1 (CB1) antagonist with an IC50 of 8nM and a G protein-coupled receptor 55 (GPR55) agonist with an EC50 of 39nM.
-
GC15093
AM4113
AM4113
AM4113 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM.
-
GC10147
AM630
6-Iodopravodoline
AM630 is a potent and selective CB2 receptor inverse agonist.
-
GC14661
AM6545
CB1 selective neutral antagonist
-
GC35339
Anandamide
AEA, Anandamide
Anandamide, an endocannabinoid derived from arachidonic acid-containing membrane lipids, exerts its actions by binding and activating CB1 and CB2 receptors (cannabinoid receptors 1 and 2) and the vanilloid transient receptor potential vanilloid 1 (TRPV1) receptor.
-
GC18435
Arachidonoyl 2'-Chloroethylamide
ACEA, 2'chloroAEA
A potent and selective CB1 receptor agonist
-
GC16826
Arachidonoyl amide
Arachidonamide,Arachidonic Acid amide
CB1 receptor agonist
-
GC18097
Arachidonoyl Serinol
CB1 receptor agonist
-
GC11849
Arachidonyl serotonin
AA5HT
Arachidonyl serotonin (Arachidonyl serotonin; AA-5-HT) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 value of 1~12 μM.
-
GC10205
Arvanil
NVanillylarachidonamide
Cannabinoid CB1 and vanilloid TRPV1 (VR1) agonist
-
GC14115
AVE-1625
Drinabant
AVE-1625 (AVE1625) is an orally active CB1 receptor antagonist.
-
GC62855
AZD1940
AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively.
-
GC61778
BAY 38-7271
BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively.
-
GC19060
Bay 59-3074
Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively .
-
GC11376
BML-190
BML-190, Indomethacin Morpholinylamide, LM-4131
CB2 receptor ligand
-
GC66030
CB1 agonist 1
CB1 agonist 1 (compound 22) is an agonist of CB1. CB1 agonist 1 shows affinity to CB1 receptor with an pIC50 value of 5.7. CB1 agonist 1 can be used for the research of brain disorders.
-
GC31306
CB1 antagonist 1
CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.
-
GC30935
CB1-IN-1
CB1-IN-1 (BPRCB1184) is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively.
-
GC71002
CB1/2 agonist 1
CB1/2 agonist 1 is a potent and cross the blood-brain barrier CB1/2 agonist with EC50s of 56.15, 11.63 nM for CB1R and CB2R, respectively.
-
GC71112
CB1/2 agonist 3
CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist.
-
GC71118
CB1R antagonist 1
-
GC70732
CB2 modulator 1
CB2 modulator 1 (compound 130) is a potent CB2 modulator.
-
GC71206
CB2R antagonist 3
CB2R antagonist 3 is a selective antagonist of cannabinoid type 2 receptor (CB2R).
-
GC33756
CB2R-IN-1
CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM.
-
GC18110
COR 170
inverse agonist of CB2 receptors
-
GC17205
CP-945598 HCl
Otenabant
CP-945598 HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.
-
GC50579
Ec2la
Ec2la is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator.
-
GC15297
GP 2a
New Product
-
GC70224
GW 833972A
GW 833972A is a selective CB2 receptor agonist.
-
GC72818
GW405833 hydrochloride
L768242 hydrochloride
GW-405833 (L768242) drochloride is a potent, selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 50.7 nM.
-
GC11760
GW842166X
Cannabinoid receptor agonist
-
GC17133
Hemopressin (human, mouse)
CB1 receptor inverse agonist; endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE
-
GC17116
Hemopressin (rat)
selective CB1 receptor inverse agonist
-
GC13965
HU 308
CB2-receptor agonist
-
GC13660
JD5037
inverse agonist at CB1 receptors
-
GC16644
JTE 907
cannabinoid CB2 receptor inverse agonist
-
GC18496
Leelamine (hydrochloride)
Dehydroabietylamine
Leelamine is a diterpene molecule whose name derives from the Sanskrit word leela which means 'play'- It has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 uM.
-
GC50273
LEI 101 hydrochloride
Potent and selective CB2 partial agonist; orally biovailable
-
GC12538
LH 21
silent CB1 antagonist
-
GC13318
LY 320135
CB1 receptor antagonist/inverse agonist
-
GC19231
LY2828360
LY2828360 is a slowly acting but efficacious G protein-biased cannabinoid (CB2) agonist, inhibiting cAMP accumulation and activating ERK1/2 signaling.
-
GC12420
MAFP
MAFP
cPLA2 and iPLA2 inhibitor, potent FAAH inhibitor
-
GC36579
MDA 19
-
GC15788
MJ 15
CB1 receptor antagonist
-
GC11453
ML-191
CCG-152883,CID-23612552
inhibitor of LPI-induced phosphorylation of ERK1/2
-
GC14626
MM-22
biotinylated anandamide analog acts as a probe for visualizing the accumulation and intracellular trafficking of anandamide
-
GC71262
Monlunabant
Monlunabant ((S)-MRI-1891) is a solid dispersions compound, as well as a cannabinoid CB1 receptor inhibitor.
-
GC70724
MRL-650
MRL-650 (CB1 inverse agonist 1) is a highly potent, orally active, and specific inverse agonist of CB1 receptor with IC50s of 7.5 nM and 4100 nM for CB1 and CB2 receptors, respectively.
-
GC14750
N-Arachidonylglycine
N-Arachidonyl Glycine, NAGly
N-Arachidonylglycine is a potent GPR18 agonist with an EC50 value of 44.5nM.
-
GC31536
N-Oleoyl glycine
A putative substrate for peptidyl glycine αamidating enzyme
-
GC18041
NESS 0327
extremely potent cannabinoid (CB) receptor antagonist
-
GC13267
NIDA 41020
CB1 receptor antagonist
-
GC69562
Nimacimab
RYI-018
Nimacimab (RYI-018) is a negative allosteric modulating monoclonal antibody that targets the CB1 receptor. Nimacimab can be used in research on metabolic diseases.
-
GC17699
O-1821
Cannabidiorcin, Cannabidiorcol, Cannabidiorocol, CBD-C1, CBDO
cannabidiol analog with close structural similarity to O-1918 which is a selective antagonist of abnormal cannabidiol
-
GC13847
O-1918
endothelial anandamide receptor antagonist
-
GC14042
Oleamide
cis9Octadecenamide
CB1 cannabinoid receptor agonist
-
GC30966
Olivetol
5-n-Amylresorcinol, 5-Pentylresorcinol
Olivetol is a naturally phenol found in lichens and produced by certain insects, acting as a competitive inhibitor of the cannabinoid receptors CB1 and CB2.
-
GC30504
Olorinab (APD 371)
APD 371
Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist, with an EC50 of 6.2 nM for hCB2.
-
GC10664
Org 27569
Cannabinoid CB1 receptor allosteric modulator
-
GC10843
Otenabant
-
GC16548
Palmitoylisopropylamide
PIA
FAAH inhibitor
-
GC14461
PB-22
QUPIC
Synthetic cannabinoid
-
GC16171
PF 514273
CB1 receptor antagonist
-
GC70955
PGN36
PGN36 (Compound 18) is a selective cannabinoid CB2 receptor (CB2R) antagonist with a Ki of 0.09 µM.
-
GC50387
PM 226
Potent and selective CB2 receptor agonist; BBB permeable; neuroprotective
-
GC12920
Pregnenolone
NSC 1616, NSC 18158, 3β-hydroxy-5-Pregnen-20-one, Δ5-Pregnenolone
steroid hormone
-
GC36963
Pregnenolone monosulfate
3β-Hydroxy-5-pregnen-20-one monosulfate
Pregnenolone monosulfate is a key precursor to various steroid hormones, including steroid hormones, and possesses multiple biological functions.
-
GC44680
Pregnenolone sulfate (sodium salt)
3β-Hydroxy-5-pregnen-20-one monosulfate sodium
Pregnenolone sulfate (sodium salt), a neuroactive metabolite of pregnenolone, exhibits the IC50 value of 26±2μmol/L for the aminobutyric acid type A receptor (GABAAR) and the IC50 value of 18±3μmol/L for GABAAR without the γ subunit.
-
GC65106
Pregnenolone-d4-1
-
GC50435
PSB CB5
CID-85469571
Selective GPR18 antagonist
-
GC74008
PSB-KK1415
PSB-KK1415 is a selective agonist for human orphan G protein-coupled receptor GPR18, with EC50 of 19.1 nM.
-
GC50143
PSNCBAM-1
Negative allosteric modulator of CB1 receptors
-
GC14177
R-1 Methanandamide Phosphate
R-1MAP,(R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate
CB1 receptor agonist
-
GC13190
R-Palmitoyl-(1-methyl) Ethanolamide
R-1 PMA
synthetic analog of palmitoyl ethanolamide (PEA)
-
GC17259
Rimonabant
SR141716
CB1 receptor antagonist
-
GC16466
Rimonabant hydrochloride
A potent and selective CB1 receptor antagonist
-
GC63617
RTICBM-189
RTICBM-189 is a potent, brain-penetrant allosteric modulator of the cannabinoid type-1 (CB1) receptor with a pIC50 of 7.54 in Ca2+ mobilization assay.
-
GC66413
RVD-Hpα TFA
RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allosteric modulator (Ki=50 nM).
-
GC13605
S-1 Methanandamide
(S)-(−)-Arachidonyl-1'-Hydroxy-2'-Propylamide
CB1 receptor ligand
-
GC12868
S-2 Methanandamide
(S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide
potent CB1 receptor agonist
-
GC67972
S-777469
-
GC50271
SCH 336
SCH-225336
Highly potent and selective CB2 inverse agonist
-
GC10032
SR 144528
SR144528
SR 144528 is a highly potent, selective, and orally active antagonist for the CB2 receptor, with a Ki value of 0.6nM.
-
GC15574
Taranabant
MK-0364
A CB1 receptor inverse agonist
-
GC37737
Taranabant ((1R,2R)stereoisomer)
MK0364 (1R,2R)stereoisomer
Taranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant.
-
GC37738
Taranabant racemate
MK-0364 racemate
Taranabant racemate (MK-0364 racemate) is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1.
-
GC10646
TC-C 14G
CB1 receptor inverse agonist
-
GC65277
Tedalinab
GRC-10693
Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist.